Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
04 08 2020
Historique:
received: 06 03 2020
revised: 09 06 2020
accepted: 14 07 2020
entrez: 7 8 2020
pubmed: 7 8 2020
medline: 4 5 2021
Statut: ppublish

Résumé

The NADase SARM1 is a central switch in injury-activated axon degeneration, an early hallmark of many neurological diseases. Here, we present cryo-electron microscopy (cryo-EM) structures of autoinhibited (3.3 Å) and active SARM1 (6.8 Å) and provide mechanistic insight into the tight regulation of SARM1's function by the local metabolic environment. Although both states retain an octameric core, the defining feature of the autoinhibited state is a lock between the autoinhibitory Armadillo/HEAT motif (ARM) and catalytic Toll/interleukin-1 receptor (TIR) domains, which traps SARM1 in an inactive state. Mutations that break this lock activate SARM1, resulting in catastrophic neuronal death. Notably, the mutants cannot be further activated by the endogenous activator nicotinamide mononucleotide (NMN), and active SARM1 is product inhibited by Nicotinamide (NAM), highlighting SARM1's functional dependence on key metabolites in the NAD salvage pathway. Our studies provide a molecular understanding of SARM1's transition from an autoinhibited to an injury-activated state and lay the foundation for future SARM1-based therapies to treat axonopathies.

Identifiants

pubmed: 32755591
pii: S2211-1247(20)30984-0
doi: 10.1016/j.celrep.2020.107999
pii:
doi:

Substances chimiques

Armadillo Domain Proteins 0
Cytoskeletal Proteins 0
SARM1 protein, mouse 0
NAD 0U46U6E8UK
Nicotinamide Mononucleotide 1094-61-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107999

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests M.B., D.A.T., S.L., P.M., Y.-S.Y., G.D., T.C.B., J.D., A.C., J.A.K., S.P.B., and S.S. are employees or former employees of Nura Bio and hold Nura Bio stock.

Auteurs

Matthew Bratkowski (M)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Tian Xie (T)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Desiree A Thayer (DA)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Shradha Lad (S)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Prakhyat Mathur (P)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Yu-San Yang (YS)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Gregory Danko (G)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Thomas C Burdett (TC)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Jean Danao (J)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Aaron Cantor (A)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Jennifer A Kozak (JA)

Chemistry Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Sean P Brown (SP)

Chemistry Department, Nura Bio Inc., South San Francisco, CA 94080, USA.

Xiaochen Bai (X)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Shilpa Sambashivan (S)

Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA. Electronic address: ssambashivan@nurabio.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH